Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

4.60
Delayed Data
As of Feb 08
 -0.69 / -13.08%
Today’s Change
4.50
Today|||52-Week Range
8.79
-33.65%
Year-to-Date

Today’s Trading

Previous close5.29
Today’s open5.18
Day’s range4.50 - 5.22
Volume68,527
Average volume (3 months)88,067
Market cap$51.2M
Dividend yield--
Data as of 02/08/2016

Growth & Valuation

Earnings growth (last year)-26.14%
Earnings growth (this year)-22.07%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+16,502.46%
P/E ratioNM
Price/Sales41.26
Price/Book6.01

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp-0.02-0.98%
CPXXCelator Pharmaceutic...-0.10-7.42%
IPCIIntelliPharmaCeutics...-0.01-0.45%
SBOTStellar Biotechnolog...-0.39-6.05%
Data as of 02/08/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$1.7M
Annual profit (last year)-$10.1M
Net profit margin-609.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts

Partner Offers